Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.16 USD | +2.11% | +2.94% | -27.58% |
02/04 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
18/03 | Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index | CI |
Evolution of the average Target Price on Olema Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Olema Pharmaceuticals, Inc.
Goldman Sachs | |
HC Wainwright | |
Citigroup | |
JPMorgan Chase | |
Canaccord Genuity | |
Credit Suisse | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- OLMA Stock
- Consensus Olema Pharmaceuticals, Inc.